Dr. Nirmal Rajasekaran, is a principal research scientist - siRNA therapeutics division at Abion Inc, Seoul South Korea. He obtained his U.G degree in Pharmacy (2005) and P.G in Pharmaceutical chemistry (2008) from Dr. M.G.R Medical University. He earned his Ph.D. in Pharmacology from Seoul National University, Seoul, South Korea. His major work involves high-throughput screening, identification of potent RNAi therapy against oncogenes. Dr. Nirmal has served as Asst. Prof in BIPS, Warangal, India in 2009. Dr. Nirmal has over 10 years of research experiences in both pharmaceutical chemistry and biopharmaceuticals. He is also serving as a reviewer for national and international journals.

Oncology, RNAi Therapeutics, siRNA Nanoparticles, Protein-Protein Interaction, Cancer Research, Molecular Biology, Biopharmaceuticals, Molecular Genetics, Cellular Microbiology.